Optimizing CAR-T Therapy for Glioblastoma

Investigators discuss current and future strategies being developed to optimize chimeric antigen receptor (CAR) T cells for efficacy in patients with glioblastoma.
[Molecular Diagnosis & Therapy]
Abstract
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News